-
3 Largecap Pharma Stocks to Watch for Future Multibagger Potential: Sun Pharma, Torrent Pharma and Zydus Lifesciences
- October 16, 2026
- Posted by: Manan Bisht
- Category: Best Stocks
No Comments
3 largecap pharma stocks compared on market cap, PE, ROE, growth and institutional holding: Sun Pharma, Torrent Pharma and Zydus Lifesciences.
-
Torrent Pharmaceuticals Share Price Prediction 2027: Scenario Targets, Valuation and Technical Outlook
- October 9, 2026
- Posted by: Chaitanya Auti
- Category: Market
Torrent Pharmaceuticals share price prediction 2027: base case Rs 5,140, bull case Rs 5,246 and a conservative case of Rs 5,034, built from reported EPS growth, valuation, technical levels and shareholding data.
-
Syncom Formulations (India) Share Price Prediction 2027: Scenario Targets, Valuation and Technical Outlook
- October 9, 2026
- Posted by: Ankit Jaiswal
- Category: Market
Syncom Formulations (India) share price prediction 2027: base case Rs 27.9, bull case Rs 33.4 and a conservative case of Rs 26.7, built from reported EPS growth, valuation, technical levels and shareholding data.
-
Sun Pharmaceutical Industries Share Price Prediction 2027: Scenario Targets, Valuation and Technical Outlook
- October 9, 2026
- Posted by: Harsh Piplani
- Category: Market
Sun Pharmaceutical Industries share price prediction 2027: base case Rs 2,113, bull case Rs 2,385 and a conservative case of Rs 1,846, built from reported EPS growth, valuation, technical levels and shareholding data.
-
Neuland Laboratories Share Price Prediction 2027: Scenario Targets, Valuation and Technical Outlook
- October 9, 2026
- Posted by: Harsh Piplani
- Category: Market
Neuland Laboratories share price prediction 2027: base case Rs 25,110, bull case Rs 26,156 and a conservative case of Rs 24,064, built from reported EPS growth, valuation, technical levels and shareholding data.
-
Marksans Pharma Share Price Prediction 2027: Scenario Targets, Valuation and Technical Outlook
- October 9, 2026
- Posted by: Neeraj Pandey
- Category: Market
Marksans Pharma share price prediction 2027: base case Rs 354, bull case Rs 425 and a conservative case of Rs 339, built from reported EPS growth, valuation, technical levels and shareholding data.
-
Rupee Near 97 Against the Dollar: Which Indian Stocks Benefit From a Weaker Rupee? IT, Pharma, Chemicals, Textiles and Auto Component Exporters, Who Loses, How to Check Currency Exposure and the Risks
- October 8, 2026
- Posted by: Ankit Jaiswal
- Category: News
Rupee near 97: which Indian stocks benefit from a weaker rupee? See IT, pharma and chemical exporters, who loses and the risks.
-
3 Pharma Stocks With a Strong Future Roadmap: Sun Pharmaceutical Industries, Cipla and Dr. Reddy’s Laboratories
- October 6, 2026
- Posted by: Chaitanya Auti
- Category: Best Stocks
Sun Pharmaceutical Industries, Cipla and Dr. Reddy’s Laboratories compared on growth, margins, debt and valuation, with the roadmap and risks investors should track.
-
Novartis India Share Price Jumps Up to 10% on 5 October: How a ChrysCapital Takeover, a Rs 860.64 Open Offer Almost Nobody Used and a New Retina Drug Deal Put the Stock at 2.5 Times the Offer Price
- October 5, 2026
- Posted by: Lakshit Sharma
- Category: News
Novartis India share price jumped up to 10% on 5 October. See the ChrysCapital takeover, the unused open offer, valuation, levels and risks.
-
Symbiotec’s US Arm Signs an Exclusive Deal for Two Injectables, and the Stock Touches a Fresh 52-Week High
- October 1, 2026
- Posted by: Chaitanya Auti
- Category: News
Symbiotec’s US arm signed an exclusive deal for two injectables, and the stock hit a fresh 52-week high. Here is the deal, the levels and the risks.